Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00286728 · ClinicalTrials.gov registry record · NA

Dual Diagnosis Self-Help Referral

A NA study of Dual Diagnosis, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
287
Enrollment target
1
Study location

NCT00286728: Completed NA study of Dual Diagnosis, sponsored by VA Office of Research and Development.

NCT00286728 is a NA study of Dual Diagnosis that has completed, run by VA Office of Research and Development. The registered enrollment target is 287 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00286728, a NA study of Dual Diagnosis, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
287 participants
Enrollment target
1
Study location

Study Summary

This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.

Conditions Studied

Interventions

  • BEHAVIORAL Intensive referral to dual-focused self-help

Study Locations (1)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Trial Details

FieldValue
Enrollment Target 287 participants
Start Date 2006-04
Est. Completion 2010-09
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00286728

The ClinicalTrials.gov registry entry for NCT00286728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dual Diagnosis appearing as the primary indexed condition, and to 1 intervention - of which Intensive referral to dual-focused self-help is the first listed.

NCT00286728 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00286728 about?

NCT00286728 is a clinical study titled "Dual Diagnosis Self-Help Referral". This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.

What is the current status of trial NCT00286728?

This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2006-04. Estimated completion is 2010-09.

What conditions does trial NCT00286728 study?

This clinical trial studies the following conditions: Dual Diagnosis.

What interventions are being tested in trial NCT00286728?

The interventions under investigation include: Intensive referral to dual-focused self-help (BEHAVIORAL).

Who is sponsoring clinical trial NCT00286728?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00286728 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dual Diagnosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.